Vizgen MERFISH 2.0 Chemistry and Enhanced OmniVue Panels

Vizgen has launched the MERFISH 2.0 spatial transcriptomics chemistry and expanded OmniVue panels. Featuring an optimized RNA anchoring strategy, improved probe design, and enhanced signal amplification, MERFISH 2.0 allows users to profile more transcripts and cells than the previous chemistry. It is fully compatible with Vizgen’s high-plex in situ spatial multiomics MERScope and MERScope Ultra platforms and is optimized for studies in oncology, neuroscience, and immunology, including using formalin-fixed paraffin-embedded (FFPE) samples. Adding more antibody-drug conjugates (ADC)-related biomarkers, the expanded OmniVue panels support whole-slide samples with validated biomarkers and pre-optimized reagents, leveraging Vizgen’s high-throughput InSituPlex assays and StarVue Image Data Science pipeline for quantitative biomarker detection.